Key Financial Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Key Financial Inc’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$162K	Hold	210	–	–	0.03%	321
2025 Q4	$162K	Sell	210 -71	-25%	-$48.2K	0.03%	326
2025 Q3	$169K	Sell	281 -26	-8%	-$14.7K	0.03%	317
2025 Q2	$161K	Hold	307	–	–	0.03%	311
2025 Q1	$195K	Hold	307	–	–	0.04%	270
2024 Q4	$219K	Hold	307	–	–	0.05%	241
2024 Q3	$323K	Buy	307 +1	+0.3%	+$1.11K	0.07%	200
2024 Q2	$322K	Hold	306	–	–	0.08%	185
2024 Q1	$295K	Hold	306	–	–	0.08%	187
2023 Q4	$269K	Hold	306	–	–	0.07%	188
2023 Q3	$252K	Hold	306	–	–	0.08%	179
2023 Q2	$220K	Buy	306 +35	+13%	+$27K	0.07%	197
2023 Q1	$223K	Buy	271 +195	+257%	+$147K	0.08%	183
2022 Q4	$52.4K	Hold	76	–	–	0.02%	351
2022 Q3	$52K	Hold	76	–	–	0.02%	355
2022 Q2	$45K	Hold	76	–	–	0.02%	381
2022 Q1	$53K	Buy	76 +71	+1,420%	+$44.9K	0.03%	354
2021 Q4	$3K	Buy	+5	New	+$3.07K	﹤0.01%	791
2020 Q2	–	Sell	-105	Closed	-$50K	–	501
2020 Q1	$50K	Buy	+105	New	+$43.3K	0.05%	212

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Key Financial Inc's REGN Position: Q1 2026 in Review

Key Financial Inc held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 210 shares worth $162K. The position accounts for 0.03% of the portfolio, ranked #321.

Key Financial Inc first reported a position in REGN in Q1 2020 and has held it in 19 quarters since. The position peaked at $323K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Key Financial Inc held 210 shares of Regeneron Pharmaceuticals worth $162K as of Q1 2026.
Key Financial Inc left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
Regeneron Pharmaceuticals made up 0.03% of Key Financial Inc's portfolio in Q1 2026, its #321 holding.
Key Financial Inc first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
Key Financial Inc's Regeneron Pharmaceuticals position peaked at $323K in Q3 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.